Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Conditions:   B-ALL;   B-cell Non Hodgkin Lymphoma;   DLBCL
Interventions:   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: CD22 CAR
Sponsor:   Stanford University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 19, 2019 / by / in
Comments